<?xml version="1.0" encoding="UTF-8"?>
<document id="29117357">
	<sentence id="s1" text="To investigate genetic predispositions for MYCN-amplified neuroblastoma, we performed a meta-analysis of three genome-wide association studies totaling 615 MYCN-amplified high-risk neuroblastoma cases and 1869 MYCN-nonamplified non-high-risk neuroblastoma cases as controls using a fixed-effects model with inverse variance weighting.">
		<entity id="s1.e1" charOffset="43-47"
			type="GENE" text="MYCN" ontology_id="4613"/>
		<entity id="s1.e2" charOffset="58-71"
			type="HP" text="neuroblastoma" ontology_id="HP_0003006"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="We identified a novel locus at 3p21.31 indexed by the single nucleotide polymorphism (SNP) rs80059929 (odds ratio [OR] = 2.95, 95% confidence interval [CI] = 2.17 to 4.02, Pmeta = 6.47 × 10-12) associated with MYCN-amplified neuroblastoma, which was replicated in 127 MYCN-amplified cases and 254 non-high-risk controls (OR = 2.30, 95% CI = 1.12 to 4.69, Preplication = .02).">
		<entity id="s2.e1" charOffset="210-214"
			type="GENE" text="MYCN" ontology_id="4613"/>
		<entity id="s2.e2" charOffset="225-238"
			type="HP" text="neuroblastoma" ontology_id="HP_0003006"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="To confirm this signal is exclusive to MYCN-amplified tumors, we performed a second meta-analysis comparing 728 MYCN-nonamplified high-risk patients to identical controls.">
		<entity id="s3.e1" charOffset="39-43"
			type="GENE" text="MYCN" ontology_id="4613"/>
		<entity id="s3.e2" charOffset="54-60"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="true"/>
	</sentence>
	<sentence id="s4" text="Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR = 0.63, 95% CI = 0.53 to 0.75, Pmeta = 1.51 × 10-8; Pmeta = .95).">
		<entity id="s4.e1" charOffset="38-42"
			type="GENE" text="LMO1" ontology_id="4004"/>
		<entity id="s4.e2" charOffset="43-56"
			type="HP" text="neuroblastoma" ontology_id="HP_0003006"/>
		<entity id="s4.e3" charOffset="120-124"
			type="GENE" text="MYCN" ontology_id="4613"/>
		<entity id="s4.e4" charOffset="148-154"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e3"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
		<pair id="s4.p3" e1="s4.e3"
		    e2="s4.e4" pgr="true"/>
		<pair id="s4.p4" e1="s4.e1"
		    e2="s4.e6" pgr="true"/>
	</sentence>
	<sentence id="s5" text="Our results indicate that common genetic variation predisposes to different neuroblastoma genotypes, including the likelihood of somatic MYCN-amplification">
		<entity id="s5.e1" charOffset="76-89"
			type="HP" text="neuroblastoma" ontology_id="HP_0003006"/>
		<entity id="s5.e2" charOffset="137-141"
			type="GENE" text="MYCN" ontology_id="4613"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
</document>
